Ivica Josko, Hill Stephen
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Clin Biochem. 2019 Feb;64:57-59. doi: 10.1016/j.clinbiochem.2018.12.003. Epub 2018 Dec 10.
Aspartate aminotransferase (AST) is regularly ordered with alanine aminotransferase (ALT) to assess liver integrity. In many situations, AST testing provides little or no added clinical value, since ALT is more specific and the both enzyme activities highly correlate. The objective of this study is to determine the potential reduction in AST testing, if not performed when ALT results are within reference intervals (RI).
Results for patients >18 years of age for both AST and ALT from the same specimen were obtained for the period January 1, 2017 - December 31, 2017. We calculated frequency of AST and ALT results that had various combinations of results within and above the RI. We also investigated the clinical locations of origin for the samples.
In total 87,704 paired samples with both AST and ALT test results were recovered. The total of 73.2% of AST tests for males and 66.9% for females would be eliminated if we performed AST testing only when ALT was increased. However, 7.4% of elevated AST tests would be missed for males and 3.8% for females due to ALT being within limits. Specifically in the outpatient clinics, 79% male and 73% females paired enzyme results were within RI. Only 4% of males and 3% of females had paired results where ALT was within RI while AST > RI.
The rate of test results with increased AST while ALT is within the RI is low enough to recommend limiting AST testing only to cases where ALT is above the RI. Our recommendation for AST restriction is to begin with the hospitals outpatient clinics.
天冬氨酸转氨酶(AST)常与丙氨酸转氨酶(ALT)一起检测,以评估肝脏完整性。在许多情况下,AST检测几乎没有或根本没有额外的临床价值,因为ALT更具特异性,且两种酶的活性高度相关。本研究的目的是确定如果在ALT结果处于参考区间(RI)时不进行AST检测,AST检测可能减少的情况。
获取了2017年1月1日至2017年12月31日期间18岁以上患者同一标本的AST和ALT结果。我们计算了AST和ALT结果在RI范围内和高于RI的各种组合的频率。我们还调查了样本的临床来源地。
总共回收了87704对同时有AST和ALT检测结果的样本。如果仅在ALT升高时进行AST检测,男性73.2%的AST检测和女性66.9%的AST检测将被取消。然而,由于ALT在正常范围内,男性7.4%的AST升高检测和女性3.8%的AST升高检测将会漏检。具体在门诊,79%的男性和73%的女性酶对结果在RI范围内。只有4%的男性和3%的女性酶对结果是ALT在RI范围内而AST>RI。
ALT在RI范围内而AST升高的检测结果发生率足够低,建议仅在ALT高于RI的情况下进行AST检测。我们对AST检测限制的建议是从医院门诊开始。